DFT383

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DFT383, covering 2025-11-10 to 2025-11-10. Get the full timeline:

Most recent: Clinical Trial Update: DFT383 in Pediatric Participants With Nephropathic Cystinosis [Phase 1, Phase 2]